Literature DB >> 9501273

Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy.

D Dobbelaere1, S Sukno, S Defoort-Dhellemmes, M D Lamblin, C Largillière.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9501273     DOI： 10.1023/a:1005319632539

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  The effect of enzyme therapy in a patient with Gaucher disease type III.

Authors:  D K Bosman; C E Hollak; J M Aerts; H D Bakker
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Enzyme replacement treatment in type 1 and type 3 Gaucher's disease.

Authors:  B Bembi; M Zanatta; M Carrozzi; F Baralle; R Gornati; B Berra; E Agosti
Journal:  Lancet       Date:  1994-12-17       Impact factor: 79.321

3.  Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease.

Authors:  A Erikson; M Aström; J E Månsson
Journal:  Neuropediatrics       Date:  1995-08       Impact factor: 1.947
  3 in total
  1 in total

1.  Enzyme replacement in neuronal storage disorders in the pediatric population.

Authors:  Erika F Augustine; Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.